Navigation Links
Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012
Date:12/13/2012

1,354

945Cost of TOS

475

620

1,174

1,104Research and development

436

1,008

823

1,616Sales and marketing

680

651

1,389

1,262General and administrative

1,201

1,470

2,340

3,130  Loss from Operations($1,916)($2,469)($3,516)($4,685)Other (Loss) Income

(57)

120

223

298  Net Loss before income tax expense($1,973)($2,349)($3,293)($4,387)Income taxes

1

-

4

-  Net Loss($1,974)($2,349)($3,297)($4,387)  Earnings per share- basic and diluted($0.04)($0.05)($0.07)($0.09)Weighted average shares outstanding- basic and diluted

47,079,000

46,790,000

47,073,000

46,606,000 Condensed Consolidated Balance Sheets Balance as of  October 31, 2012(unaudited)April 30, 2012 Cash and cash equivalents

$2,161

$4,716Accounts receivable

627

584Other current assets

95

205  Total current assets2,8835,505Restricted cash

188

188Property and equipment, net

485

560Goodwill

669

669  Total assets$4,225$6,922Accounts payable and accrued liabilities

$1,723

$2,301Deferred revenue

1,205

1,185  Total current liabilities2,9283,486Warrant liability

322

555Redeemable common stock

8,159

8,159Stockholders' deficit

(7,184)

(5,278)  Total liabilities, redeemable common stock andstockholders' deficit$4,225$6,922 Condensed Consolidated Statements of Cash Flows (Unaudited)Six Months Ended October 31,20122011Cash flows from operating activities:Net Loss

($3,297)

($4,387)Adjustments to reconcile net cash used in operations:  Stock-based compensation expense

1,364

1,868
'/>"/>

SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
3. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
6. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
7. 500 Oncology Providers Sign Up for Navigating Cancers Patient Engagement Portal
8. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
9. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
10. International Oncology Innovators Meeting in Hamburg
11. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 ... ) has announced the addition of the  "Micro ... to their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... of the fastest-growing segments in the chromatography market. ... 2013, and expected to reach $2.0 billion by ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 ... urological and interventional radiology products and services, announced ... as cryotherapy and cryoablation) versus external beam radiotherapy ... of the American Urological Association (MAAUA) Annual Meeting ... "Comparing Relative Effectiveness of Cryosurgery and External Beam ...
(Date:9/18/2014)... , Sept. 18, 2014  Health Enhancement Products, Inc. (OTCQB: ... early-stage algae bioactive compounds and metabolic processes, is pleased to ... board of directors. Ms. Nola E. Masterson , a ... joined the board effective September 17, 2014. ... to join our board," states Andrew Dahl , President ...
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global and Chinese Stem Cell Industry Report, ... Stem cells are undifferentiated biological cells that can differentiate ... produce more stem cells. Stem cell therapy can be ... of hematological system disease), nervous system diseases, damage or ...
Breaking Biology Technology:Micro Market Monitor : Global Pre-packed Chromatography Columns 2HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3
... Researchers at the National Institute of Standards and Technology ... levels of stress or strain in regions of a ... recent results* not only will impact the design of ... rest a long-standing disagreement in results between two different ...
... Calif., Nov. 25 MannKind Corporation,(Nasdaq: MNKD ), ... announced today that it will present at,the Piper Jaffray 20th ... PM (EST) at the New York Palace Hotel in New ... parties can access a link to the live web cast ...
... Celator Pharmaceuticals today announced that Scott Jackson, chief executive ... Jaffray Health Care Conference in New York and the 2008 ... a corporate overview and an update on the company,s clinical ... , , ...
Cached Biology Technology:NIST 'stress tests' probe nanoscale strains in materials 2Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference 2
(Date:9/19/2014)... Oklahoma biology professor will study the unique bioelectric signaling ... eventually benefit people,s health. The OU researcher is ... required to produce the signals used to map the ... at a rate of 500-600 discharges a second throughout ... electric fish are extreme, but necessary for survival. , ...
(Date:9/19/2014)... regulate their symbiotic relationship with soil bacteria by ... plant structure from leaves into the roots to ... roots. This collaborative study was conducted by researchers ... Graduate University for Advanced Studies (SOKENDAI), and the ... , Legumes, an important plant family which ...
(Date:9/18/2014)... New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), ... in humans similar to that caused by Ebolavirus, has ... discovery has the potential to lead to novel targets ... The research, reported in a paper published today in ... scientists at the Texas Biomedical Research Institute and their ...
Breaking Biology News(10 mins):For legume plants, a new route from shoot to root 2Research milestone in CCHF virus could help identify new treatments 2
... biological processes. They consist of chains constructed of up ... and function are controlled by the genetic code. Brilliant ... to rewrite the core function of proteins by making ... biological and chemical methods, researchers are able to design ...
... NEW YORK, January 29, 2014 -- C. David Allis, a ... modifications of DNA-packaging proteins play a key role in regulating ... Japan Prize in Life Sciences. The announcement, by the Japan ... this morning. The Japan Prize, worth approximately half a ...
... BOSTON In recent years, mutations in two metabolic enzymes, ... in approximately 20 percent of all acute myeloid leukemias (AML). ... attractive drug targets for this common form of adult leukemia. ... Center (BIDMC) has generated a transgenic mouse model of ...
Cached Biology News:Designer proteins provide new information about the body's signal processes 2David Allis, pioneer in epigenetics, to receive prestigious Japan Prize 2Animal model demonstrates role for metabolic enzyme in acute myeloid leukemia 2Animal model demonstrates role for metabolic enzyme in acute myeloid leukemia 3
...
...
MultiWash III w/ 12-portStandard Manifold...
... Sepharose High Performance, 5 ml. The ... in HiTrap Streptavidin columns for fast, ... packing into Tricorn 5/50 GL, XK ... scale purifications are required.Extremely useful for ...
Biology Products: